| Pharmaceutical active ingredients: |
| Drofenine HydrochloridePropyphenazone |
| Available forms, composition and doses of Spasmo-Cibalgin: |
| Suppositories; Rectal; Drofenine Hydrochloride; PropyphenazoneTablets; Oral; Drofenine Hydrochloride; Propyphenazone |
| Spasmo-Cibalgin medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N02BB54 - Propyphenazone, combinations excluding psycholeptics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Novartis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Spasmocalm | Phloroglucinol | Cooperation Pharmaceutique Francaise |
| Spasmocan | Camylofin | Unidentified Pharmaceutical Company |
| Spasmo-Canulase N | Dimethicone; Methixene Hydrochloride; Pancreatin Porcine | Novartis |
| Spasmocarbine | Belladonna; Betanaphthyl Benzoate; Charcoal Activated; Crataegus; Hyoscyamus; Magnesium Bromide; Methenamine; Passion Flower | GlaxoSmithKline |
| Spasmo-CC | Greater Celandine; Turmeric | Steiner & Co. Deutsche Arzneimittel Gesellschaft |
| Spasmo-Cibalgin Comp | Codeine Phosphate; Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgin Compositum S | Codeine Phosphate; Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgin S | Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgina | Drofenine Hydrochloride; Propyphenazone | Novartis |
| Spasmo-Cibalgine | Drofenine Hydrochloride; Propyphenazone | Novartis |